These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 24662746

  • 1. Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition.
    Jing Y, Cui D, Guo W, Jiang J, Jiang B, Lu Y, Zhao W, Wang X, Jiang Q, Han B, Xia S.
    Cancer Lett; 2014 Jun 28; 348(1-2):135-45. PubMed ID: 24662746
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.
    Urol Oncol; 2014 Aug 28; 32(6):855-63. PubMed ID: 24968949
    [Abstract] [Full Text] [Related]

  • 4. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K, Zeng J, Zhou J, Fan J, Chen Y, Wang Z, Zhang T, Wang X, He D.
    Urol Oncol; 2013 Nov 28; 31(8):1751-60. PubMed ID: 22421353
    [Abstract] [Full Text] [Related]

  • 5. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D, Liou Y, Shu J, Li D, Zhang L, Chen J.
    Exp Mol Pathol; 2014 Jun 28; 96(3):411-21. PubMed ID: 24768914
    [Abstract] [Full Text] [Related]

  • 6. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
    Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z.
    Oncogene; 2014 May 22; 33(21):2737-47. PubMed ID: 23752181
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z, You T.
    Cancer Lett; 2014 Dec 01; 355(1):130-40. PubMed ID: 25218351
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H, Wang YL, Wang GW, Wong YC, Wang XF, Wang Y, Xu KX.
    Urol Oncol; 2013 Oct 01; 31(7):1242-53. PubMed ID: 22226665
    [Abstract] [Full Text] [Related]

  • 11. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD, Sun GB, Jiao P, Chen C, Liu QF, Huang XL, Zhang R, Cai WY, Li SN, Wu JF, Liu YJ, Wu RS, Xie YY, Chan EC, Liou YC, Li BA.
    Gastroenterology; 2016 Mar 01; 150(3):659-671.e16. PubMed ID: 26619963
    [Abstract] [Full Text] [Related]

  • 12. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
    Douchi D, Ohtsuka H, Ariake K, Masuda K, Kawasaki S, Kawaguchi K, Fukase K, Oikawa M, Motoi F, Naitoh T, Katayose Y, Egawa S, Unno M.
    Cancer Lett; 2015 Aug 28; 365(1):132-40. PubMed ID: 26047573
    [Abstract] [Full Text] [Related]

  • 13. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
    Wu J, Ru NY, Zhang Y, Li Y, Wei D, Ren Z, Huang XF, Chen ZN, Bian H.
    Oncogene; 2011 Oct 27; 30(43):4410-27. PubMed ID: 21532623
    [Abstract] [Full Text] [Related]

  • 14. Androgen activates β-catenin signaling in bladder cancer cells.
    Li Y, Zheng Y, Izumi K, Ishiguro H, Ye B, Li F, Miyamoto H.
    Endocr Relat Cancer; 2013 Jun 27; 20(3):293-304. PubMed ID: 23447569
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X, Zheng K, Li C, Zhao Y, Li H, Liu X, Long Y, Yao J.
    Oncol Rep; 2017 May 27; 37(5):2847-2856. PubMed ID: 28339056
    [Abstract] [Full Text] [Related]

  • 17. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q, Liu J.
    Prostate; 2015 Jun 15; 75(9):957-68. PubMed ID: 25728945
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer.
    Zhou Q, Chen S, Lu M, Luo Y, Wang G, Xiao Y, Ju L, Wang X.
    Int J Biol Sci; 2019 Jun 15; 15(10):2139-2155. PubMed ID: 31592144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.